drugset / Trial / NCT02840591
Ramelteon and Citicoline for Delirium
Non-randomizedParallel-groupOpen-labelOther
Summary
Primary aim of this study is to assess the feasibility of conducting clinical research for delirium (confusion due to medical problems) at Clements University Hospital in Dallas, Texas. A secondary aim is to assess whether an FDA-approved sleeping aid called Ramelteon or an over-the-counter supplement called Citicoline are safe and beneficial in delirium.
Timeline
- Start
- 2016-07
- Primary completion
- 2017-11
- Completion
- 2017-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Citicoline | Other / unclassified | 500 mg | — |
| Subject | Ramelteon | Unknown | 8 mg | — |